DIFLUCAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diflucan, and when can generic versions of Diflucan launch?
Diflucan is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in DIFLUCAN is fluconazole. There are twenty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the fluconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diflucan
A generic version of DIFLUCAN was approved as fluconazole by CHARTWELL on July 29th, 2004.
Summary for DIFLUCAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 157 |
Clinical Trials: | 40 |
Patent Applications: | 4,202 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DIFLUCAN |
Drug Sales Revenues: | Drug sales revenues for DIFLUCAN |
What excipients (inactive ingredients) are in DIFLUCAN? | DIFLUCAN excipients list |
DailyMed Link: | DIFLUCAN at DailyMed |
Recent Clinical Trials for DIFLUCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
CSPC Ouyi Pharmaceutical Group Co., Ltd. | N/A |
Peking Union Medical College Hospital | N/A |
Maastricht University Medical Center | Phase 3 |
Pharmacology for DIFLUCAN
Drug Class | Azole Antifungal |
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C9 Inhibitors Cytochrome P450 3A4 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for DIFLUCAN
US Patents and Regulatory Information for DIFLUCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DIFLUCAN | fluconazole | FOR SUSPENSION;ORAL | 020090-001 | Dec 23, 1993 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER | fluconazole | INJECTABLE;INJECTION | 019950-003 | Sep 29, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-002 | Jan 29, 1990 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DIFLUCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-004 | Jun 30, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-002 | Jan 29, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | DIFLUCAN | fluconazole | FOR SUSPENSION;ORAL | 020090-002 | Dec 23, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DIFLUCAN
See the table below for patents covering DIFLUCAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 541154 | ⤷ Try a Trial | |
Philippines | 18015 | ANTIFUNGAL BIS-TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Try a Trial |
Australia | 7087781 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |